Provided by Tiger Fintech (Singapore) Pte. Ltd.

Geron

1.35
+0.08006.30%
Volume:15.60M
Turnover:21.19M
Market Cap:859.82M
PE:-5.00
High:1.43
Open:1.27
Low:1.27
Close:1.27
Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Geron (GERN), Genmab (GMAB) and Elanco Animal Health (ELAN)

TIPRANKS
·
4 hours ago

Geron Corp : Leerink Partners Cuts Target Price to $3 From $5

THOMSON REUTERS
·
Yesterday

Is Geron Corp. (NASDAQ:GERN) the Most Promising Penny Stock According to Analysts?

Insider Monkey
·
18 Apr

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey
·
16 Apr

Should You Invest in Geron Corporation (GERN)?

Insider Monkey
·
08 Apr

Press Release: Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

Dow Jones
·
01 Apr

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?

Simply Wall St.
·
27 Mar

Is Geron Corporation (NASDAQ:GERN)  The Top Penny Stock That Will Skyrocket?

Insider Monkey
·
26 Mar

BRIEF-Geron reports inducement grants under Nasdaq listing rule 5635(C)(4)

Reuters
·
20 Mar

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
20 Mar

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
20 Mar

Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts?

Insider Monkey
·
18 Mar

Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP

TIPRANKS
·
14 Mar

Geron Anemia Treatment Wins European Commission Approval

MT Newswires Live
·
12 Mar

BRIEF-Geron Announces EC Approval For RYTELO To Treat Transfusion-Dependent Anemia

Reuters
·
12 Mar

Geron Corp: Ec Approval for Rytelo to Treat Transfusion-Dependent Anemia in Lower-Risk Mds Adults

THOMSON REUTERS
·
12 Mar

Geron CEO John Scarlett to Depart; Dawn Carter Bir Named in Interim

MT Newswires Live
·
12 Mar

Geron Launches CEO Search as Scarlett Steps Down

Dow Jones
·
12 Mar

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS

Business Wire
·
12 Mar

Geron CEO Scarlett to leave company

TIPRANKS
·
12 Mar